Literature DB >> 22093503

Myocardial expression levels of micro-ribonucleic acids in patients with left ventricular assist devices signature of myocardial recovery, signature of reverse remodeling, or signature with no name?

Douglas L Mann, Daniel Burkhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22093503     DOI： 10.1016/j.jacc.2011.09.007

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  7 in total

Review 1.  Is myocardial recovery possible and how do you measure it?

Authors:  Douglas L Mann; Daniel Burkhoff
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

2.  Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li
Journal:  Circulation       Date:  2012-07-10       Impact factor: 29.690

Review 3.  Hold or fold--proteins in advanced heart failure and myocardial recovery.

Authors:  Claudius Mahr; Rebekah L Gundry
Journal:  Proteomics Clin Appl       Date:  2015-01-02       Impact factor: 3.494

4.  Foreword.

Authors: 
Journal:  Interv Cardiol       Date:  2022-06-29

Review 5.  Myocardial recovery and the failing heart: myth, magic, or molecular target?

Authors:  Douglas L Mann; Philip M Barger; Daniel Burkhoff
Journal:  J Am Coll Cardiol       Date:  2012-11-14       Impact factor: 24.094

6.  Treatment strategies for myocardial recovery in heart failure.

Authors:  Andrew J Lenneman; Emma J Birks
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-03

7.  MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices.

Authors:  Sjoukje I Lok; Nicolaas de Jonge; Joyce van Kuik; Ankie J P van Geffen; Manon M H Huibers; Petra van der Weide; Erica Siera; Bjorn Winkens; Pieter A Doevendans; Roel A de Weger; Paula A da Costa Martins
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.